NOVONIX LTD-ADR (NVX) Fundamental Analysis & Valuation

NASDAQ:NVX • US67010L1008

Current stock price

0.79 USD
-0.01 (-1.62%)
Last:

This NVX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NVX Profitability Analysis

1.1 Basic Checks

  • In the past year NVX has reported negative net income.
  • NVX had a negative operating cash flow in the past year.
  • NVX had negative earnings in each of the past 5 years.
  • NVX had a negative operating cash flow in each of the past 5 years.
NVX Yearly Net Income VS EBIT VS OCF VS FCFNVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • NVX's Return On Assets of -32.77% is on the low side compared to the rest of the industry. NVX is outperformed by 78.23% of its industry peers.
  • With a Return On Equity value of -57.35%, NVX is not doing good in the industry: 79.03% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -32.77%
ROE -57.35%
ROIC N/A
ROA(3y)-27.81%
ROA(5y)-21.66%
ROE(3y)-45.63%
ROE(5y)-33.21%
ROIC(3y)N/A
ROIC(5y)N/A
NVX Yearly ROA, ROE, ROICNVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NVX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NVX Yearly Profit, Operating, Gross MarginsNVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. NVX Health Analysis

2.1 Basic Checks

  • NVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NVX has more shares outstanding
  • Compared to 5 years ago, NVX has more shares outstanding
  • The debt/assets ratio for NVX is higher compared to a year ago.
NVX Yearly Shares OutstandingNVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NVX Yearly Total Debt VS Total AssetsNVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • Based on the Altman-Z score of -1.24, we must say that NVX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.24, NVX is doing worse than 80.65% of the companies in the same industry.
  • A Debt/Equity ratio of 0.23 indicates that NVX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.23, NVX is doing worse than 60.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -1.24
ROIC/WACCN/A
WACC8.73%
NVX Yearly LT Debt VS Equity VS FCFNVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • NVX has a Current Ratio of 1.07. This is a normal value and indicates that NVX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.07, NVX is not doing good in the industry: 89.52% of the companies in the same industry are doing better.
  • NVX has a Quick Ratio of 1.04. This is a normal value and indicates that NVX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.04, NVX is not doing good in the industry: 80.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.04
NVX Yearly Current Assets VS Current LiabilitesNVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. NVX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.80% over the past year.
  • The Revenue for NVX has decreased by -17.21% in the past year. This is quite bad
  • NVX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.19% yearly.
EPS 1Y (TTM)12.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.11%
Revenue 1Y (TTM)-17.21%
Revenue growth 3Y-9.97%
Revenue growth 5Y2.19%
Sales Q2Q%-10.1%

3.2 Future

  • Based on estimates for the next years, NVX will show a very negative growth in Earnings Per Share. The EPS will decrease by -39.38% on average per year.
  • The Revenue is expected to grow by 73.46% on average over the next years. This is a very strong growth
EPS Next Y25%
EPS Next 2Y32.29%
EPS Next 3Y-77.95%
EPS Next 5Y-39.38%
Revenue Next Year1344.85%
Revenue Next 2Y426.31%
Revenue Next 3Y108.72%
Revenue Next 5Y73.46%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVX Yearly Revenue VS EstimatesNVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
NVX Yearly EPS VS EstimatesNVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. NVX Valuation Analysis

4.1 Price/Earnings Ratio

  • NVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NVX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NVX Price Earnings VS Forward Price EarningsNVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NVX Per share dataNVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

  • NVX's earnings are expected to decrease with -77.95% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.29%
EPS Next 3Y-77.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NVX Dividend Analysis

5.1 Amount

  • NVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NVX Fundamentals: All Metrics, Ratios and Statistics

NOVONIX LTD-ADR

NASDAQ:NVX (4/16/2026, 12:01:03 PM)

0.79

-0.01 (-1.62%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners12.39%
Inst Owner Change-0.35%
Ins Owners1.88%
Ins Owner Change0%
Market Cap170.13M
Revenue(TTM)5.62M
Net Income(TTM)-92.73M
Analysts84
Price Target1.43 (81.01%)
Short Float %2.26%
Short Ratio7.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.17%
EPS NY rev (3m)-14.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 30.29
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.14
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.03
BVpS0.75
TBVpS0.7
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -32.77%
ROE -57.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-27.81%
ROA(5y)-21.66%
ROE(3y)-45.63%
ROE(5y)-33.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1071.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.04
Altman-Z -1.24
F-Score3
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)606.86%
Cap/Sales(5y)644.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.11%
EPS Next Y25%
EPS Next 2Y32.29%
EPS Next 3Y-77.95%
EPS Next 5Y-39.38%
Revenue 1Y (TTM)-17.21%
Revenue growth 3Y-9.97%
Revenue growth 5Y2.19%
Sales Q2Q%-10.1%
Revenue Next Year1344.85%
Revenue Next 2Y426.31%
Revenue Next 3Y108.72%
Revenue Next 5Y73.46%
EBIT growth 1Y2.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.31%
EBIT Next 3Y19.18%
EBIT Next 5Y15.09%
FCF growth 1Y-45.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.41%
OCF growth 3YN/A
OCF growth 5YN/A

NOVONIX LTD-ADR / NVX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NOVONIX LTD-ADR (NVX) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NVX.


Can you provide the valuation status for NOVONIX LTD-ADR?

ChartMill assigns a valuation rating of 0 / 10 to NOVONIX LTD-ADR (NVX). This can be considered as Overvalued.


Can you provide the profitability details for NOVONIX LTD-ADR?

NOVONIX LTD-ADR (NVX) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NOVONIX LTD-ADR?

The Earnings per Share (EPS) of NOVONIX LTD-ADR (NVX) is expected to grow by 25% in the next year.